
OCCL Q3 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 4- Global market expected to grow at about 2% to 2.5% annually over the next two years.
- Company focusing on increasing volumes by retaining and expanding business in India and international markets.
- Efforts underway to secure and maintain anti-dumping duties to protect market share, especially in India.
- Current global industry capacity utilization around 70%-75%; capacity expansion to be considered once utilization exceeds 90%-95%.
- Next phase expansion earmarked in Dharuhera but deferred due to market slowdown.
- Pricing under pressure mainly due to competition; further significant price declines are unlikely.
- Company aims to stabilize operations first and leverage efficient capacity utilization as demand recovers.
- No immediate plans to diversify beyond insoluble sulphur; focus remains on core chemical business growth.
See what OCCL management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what OCCL management said on order book — free account, 30 seconds.
Capex plans
Yes- The company has entered into a contract for captive power consumption and expects to start receiving power for its Haryana plant from April (Page 12).
- The phase two expansion for insoluble sulphur capacity is planned but deferred due to the current market slowdown. The capital expenditure for this expansion is not finalized, but the last expansion cost around INR 150 crores (Page 12).
- Expansion will be considered once capacity utilization crosses 90%-95%. Currently, utilization is around 75%-80% (Pages 5, 6).
- The management is open to exploring global alliances and partnerships but believes such moves depend on the core business performing better and improved market capitalization (Page 13).
- No immediate plans for buyback as the company recently underwent a demerger and reduced face value (Page 14).
Track OCCL — get its next earnings analysis in your feed
How does OCCL rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does OCCL rank in Chemicals & Petrochemicals?
Compare OCCL against every Chemicals & Petrochemicals company (Q3 FY25) on revenue, margins and earnings-call signals.
Continue your research
What OCCL's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…